Indaba Capital Announces Sale of AST Revolution to Bruker
Bruker Corporation (BRKR)
Last bruker corporation earnings: 10/31 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.bruker.com/investors/default.aspx
Company Research
Source: Business Wire
SAN FRANCISCO--(BUSINESS WIRE)--Indaba Capital Management, L.P. (“Indaba”), controlling shareholder of AST Revolution, LLC (“AST Revolution” or the “Company”), today announced the sale of AST Revolution to Bruker Corporation (“Bruker”) (Nasdaq: BRKR, BRKRP), a leading provider of advanced scientific instruments and analytical solutions for life sciences and materials research. Financial terms of the transaction were not disclosed.The transaction follows AST Revolution’s launch in August 2025 as an in vitro diagnostics company focused on developing next-generation rapid antimicrobial susceptibility testing (AST) solutions that improve patient outcomes and lower healthcare costs. AST Revolution was formed after the completion of a court-approved acquisition of select assets of Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) under the Chapter 11 process, including the Accelerate Diagnostics WAVE™ and Arc™ systems and associated intellectual property portfolio.With Indaba’s su
Show less
Read more
Impact Snapshot
Event Time:
BRKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRKR alerts
High impacting Bruker Corporation news events
Weekly update
A roundup of the hottest topics
BRKR
News
- Bruker (NASDAQ:BRKR) was upgraded by analysts at Rothschild Redb to a "strong-buy" rating.MarketBeat
- Bruker (NASDAQ:BRKR) was given a new $60.00 price target on by analysts at Redburn Partners.MarketBeat
- Bruker (NASDAQ:BRKR) is now covered by analysts at Rothschild & Co Redburn. They set a "buy" rating and a $60.00 price target on the stock.MarketBeat
- Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum [Yahoo! Finance]Yahoo! Finance
- Bruker (NASDAQ:BRKR) had its price target lowered by analysts at Wells Fargo & Company from $50.00 to $48.00. They now have an "overweight" rating on the stock.MarketBeat
BRKR
Earnings
- 11/3/25 - Beat
BRKR
Sec Filings
- 12/2/25 - Form 4
- 12/1/25 - Form 144
- 11/14/25 - Form SCHEDULE
- BRKR's page on the SEC website